1995
Temporal Trends of Incident Human Immunodeficiency Virus Infection in a Cohort of Injecting Drug Users in Baltimore, Md
Nelson K, Vlahov D, Solomon L, Cohn S, Muñoz A. Temporal Trends of Incident Human Immunodeficiency Virus Infection in a Cohort of Injecting Drug Users in Baltimore, Md. JAMA Internal Medicine 1995, 155: 1305-1311. PMID: 7778962, DOI: 10.1001/archinte.1995.00430120091011.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virus (HIV) infectionImmunodeficiency virus infectionHuman immunodeficiency virusDrug usersVirus infectionImmunodeficiency virusEffective human immunodeficiency virus (HIV) vaccineHuman immunodeficiency virus risk factorsIncident human immunodeficiency virus (HIV) infectionsHuman immunodeficiency virus (HIV) seroconversionHuman immunodeficiency virus (HIV) antibodyHuman immunodeficiency virus (HIV) vaccinesIllicit drug injectionInjecting Drug UsersHigh-risk populationImmunodeficiency virus vaccinesIncidence of infectionPrevention of infectionSterile injection equipmentEnzyme-linked immunosorbent assaySeronegative participantsStudy clinicAnnual incidenceImmunodeficiency syndromeOverall incidence
1994
Preparations for AIDS vaccine trials. Incident human immunodeficiency virus (HIV) infections in a cohort of injection drug users in Baltimore, Maryland.
Nelson K, Vlahov D, Galai N, Astemborski J, Solomon L. Preparations for AIDS vaccine trials. Incident human immunodeficiency virus (HIV) infections in a cohort of injection drug users in Baltimore, Maryland. AIDS Research And Human Retroviruses 1994, 10 Suppl 2: s201-5. PMID: 7865301.Peer-Reviewed Original ResearchConceptsInjection drug usersHIV incidenceIncident human immunodeficiency virus (HIV) infectionsDrug usersHIV vaccine trial participationHuman immunodeficiency virus (HIV) infectionRisk behaviorsCohort of IDUsHuman immunodeficiency virus (HIV) vaccinesHIV-seronegative subjectsHigh HIV incidenceImmunodeficiency virus infectionAIDS vaccine trialsVaccine trial participationImmunodeficiency virus vaccinesHigh-risk behaviorsHIV seroconversionAnnual incidenceHIV vaccineNeedle sharingTrial participationVaccine trialsVirus vaccineVirus infectionStudy subjects